Holen Sie sich die Stockscreener-App
0.8137
2.90%
-0.0243
Vorhandelsmarkt:
.80
-0.0137
-1.68%
Schlusskurs vom Vortag:
$0.838
Offen:
$0.8229
24-Stunden-Volumen:
204.96K
Relative Volume:
1.78
Marktkapitalisierung:
$6.06M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-16.28M
KGV:
-0.0585
EPS:
-13.91
Netto-Cashflow:
$-13.75M
1W Leistung:
+13.28%
1M Leistung:
+11.19%
6M Leistung:
-50.98%
1J Leistung:
-78.56%
1-Tages-Spanne:
$0.723
$0.838
1-Wochen-Bereich:
$0.691
$0.84
52-Wochen-Spanne:
$0.65
$4.35
Pasithea Therapeutics Corp Stock (KTTA) Company Profile
Firmenname
Pasithea Therapeutics Corp
Sektor
Branche
Telefon
(702) 514-4174
Adresse
1111 LINCOLN ROAD, SUITE 500, MIAMI BEACH
Vergleichen Sie KTTA mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
KTTA
Pasithea Therapeutics Corp
|
0.8137 | 6.24M | 0 | -16.28M | -13.75M | -13.91 |
|
VRTX
Vertex Pharmaceuticals Inc
|
425.57 | 107.66B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
651.80 | 68.74B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
456.04 | 58.93B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
818.50 | 50.51B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
189.60 | 41.29B | 447.02M | -1.18B | -868.57M | -6.1812 |
Pasithea Therapeutics Corp Aktie (KTTA) Neueste Nachrichten
Is Pasithea Therapeutics Corp. stock a dividend growth opportunityJuly 2025 Sector Moves & Growth Focused Stock Reports - newser.com
Backtesting results for Pasithea Therapeutics Corp. Equity Warrant trading strategiesRisk Management & Consistent Income Trade Recommendations - newser.com
Is Pasithea Therapeutics Corp. stock a safe investment in uncertain marketsTreasury Yields & Weekly Market Pulse Updates - newser.com
What institutional flow reveals about Pasithea Therapeutics Corp. Equity WarrantPortfolio Return Summary & Expert Approved Momentum Trade Ideas - newser.com
Will Pasithea Therapeutics Corp. stock outperform tech sector in 2025Portfolio Risk Report & Weekly High Conviction Trade Ideas - newser.com
Is Pasithea Therapeutics Corp. Equity Warrant stock positioned for long term growthWeekly Investment Report & Entry Point Confirmation Signals - newser.com
Will Pasithea Therapeutics Corp. Equity Warrant stock continue dividend increases2025 Fundamental Recap & Smart Allocation Stock Tips - newser.com
Does Pasithea Therapeutics Corp. Equity Warrant qualify in momentum factor screening2025 Stock Rankings & Expert Curated Trade Setups - newser.com
Chart based analysis of Pasithea Therapeutics Corp. Equity Warrant trendsLayoff News & Smart Swing Trading Techniques - newser.com
Applying sector rotation models to Pasithea Therapeutics Corp. Equity WarrantJuly 2025 Patterns & Safe Entry Momentum Tips - newser.com
Real time social sentiment graph for Pasithea Therapeutics Corp. Equity WarrantOptions Play & Free Expert Verified Stock Movement Alerts - newser.com
Can Pasithea Therapeutics Corp. stock attract ESG capital inflowsEntry Point & Community Verified Trade Signals - newser.com
Will Pasithea Therapeutics Corp. Equity Warrant stock outperform value stocksWeekly Investment Report & AI Enhanced Trade Execution Alerts - newser.com
Is Pasithea Therapeutics Corp. stock cheap compared to fundamentals2025 Retail Activity & Long-Term Growth Stock Strategies - newser.com
Can Pasithea Therapeutics Corp. stock outperform in 2025 bull market2025 Volume Leaders & Technical Analysis for Trade Confirmation - newser.com
Is it too late to sell Pasithea Therapeutics Corp.CEO Change & Daily Stock Trend Reports - newser.com
Is Pasithea Therapeutics Corp. reversing from oversold territory2025 Winners & Losers & Low Risk Entry Point Guides - newser.com
Pasithea Therapeutics Corp. stock chart pattern explained2025 Dividend Review & Community Shared Stock Ideas - newser.com
Is Pasithea Therapeutics Corp. stock a buy for dividend growthWeekly Gains Report & AI Driven Price Forecasts - newser.com
Has Pasithea Therapeutics Corp. formed a bullish divergenceMarket Sentiment Review & Free High Return Stock Watch Alerts - newser.com
Short interest data insights for Pasithea Therapeutics Corp.Portfolio Gains Summary & Technical Confirmation Trade Alerts - newser.com
Pasithea Therapeutics Corp Equity Warrant Stock Analysis and ForecastPrice Support Zones & Get Mentorship from Elite Traders - earlytimes.in
Comparing Pasithea Therapeutics Corp. Equity Warrant in custom built stock radarsJuly 2025 Sector Moves & AI Driven Stock Movement Reports - newser.com
Why retail investors pile into Pasithea Therapeutics Corp. Equity Warrant stockJuly 2025 Highlights & Technical Entry and Exit Alerts - newser.com
Is Pasithea Therapeutics Corp. Equity Warrant stock supported by strong cash flowsWeekly Trade Analysis & Verified Momentum Stock Alerts - newser.com
Finanzdaten der Pasithea Therapeutics Corp-Aktie (KTTA)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.62%
0.21%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):